Citations (130)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Joyce S. Tsuji, Ellen T. Chang, P. Robinan Gentry, Harvey J. Clewell, Paolo Boffetta & Samuel M. Cohen. (2019) Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach. Critical Reviews in Toxicology 49:1, pages 36-84.
Read now
Read now
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
Read now
Karolina Orywal, Wojciech Jelski, Tadeusz Werel & Maciej Szmitkowski. (2018) The Activity of Class I-IV Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in Bladder Cancer Cells. Cancer Investigation 36:1, pages 66-72.
Read now
Read now
Samuel M. Cohen, Lora L. Arnold, Barbara D. Beck, Ari S. Lewis & Michal Eldan. (2013) Evaluation of the carcinogenicity of inorganic arsenic. Critical Reviews in Toxicology 43:9, pages 711-752.
Read now
Read now
Liang Cheng, Darrell D Davidson, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang, Michael O Koch, Rodolfo Montironi & Antonio Lopez-Beltran. (2010) The origins of urothelial carcinoma. Expert Review of Anticancer Therapy 10:6, pages 865-880.
Read now
Read now
George L. Delclos & Seth P. Lerner. (2008) Occupational risk factors. Scandinavian Journal of Urology and Nephrology 42:sup218, pages 58-63.
Read now
Read now
Chun-Ping Li, Yu-Jie Zhu, Rui Chen, Wei Wu, Ai-Ping Li, Jia Liu, Qi-Zhan Liu, Qing-Yi Wei, Zheng-Dong Zhang & Jian-Wei Zhou. (2007) Functional Polymorphisms of JWA Gene are Associated with Risk of Bladder Cancer. Journal of Toxicology and Environmental Health, Part A 70:11, pages 876-884.
Read now
Read now
Articles from other publishers (123)
Heba A.S. El-Nashar, Shaden Kocaeli, Mayar Abdallah & Mohamed El-Shazly. 2023. Marine Ecosystems: A Unique Source of Valuable Bioactive Compounds. Marine Ecosystems: A Unique Source of Valuable Bioactive Compounds
355
393
.
Shrute Kannappan, Jung Heon Lee, Muthaiyan Lakshmanakumar, Noel Nesakumar & John Bosco Balaguru Rayappan. 2021. Biomarkers and Biosensors for Cervical Cancer Diagnosis. Biomarkers and Biosensors for Cervical Cancer Diagnosis
13
22
.
Muthaiyan Lakshmanakumar, Arockia Jayalatha JBB & Noel Nesakumar. 2021. Biomarkers and Biosensors for Cervical Cancer Diagnosis. Biomarkers and Biosensors for Cervical Cancer Diagnosis
1
12
.
Fabian Achenbach, Michael Rose, Nadina Ortiz-Brüchle, Lancelot Seillier, Ruth Knüchel, Veronika Weyerer, Arndt Hartmann, Ronja Morsch, Angela Maurer, Thorsten H. Ecke, Stefan Garczyk & Nadine T. Gaisa. (2020) SWI/SNF Alterations in Squamous Bladder Cancers. Genes 11:11, pages 1368.
Crossref
Crossref
Jin Ren, Yaodong Yang, Taifang Peng & Dong Xu. (2020) Predictive value of β-catenin in bladder cancer: a systematic review and meta-analysis. Bioscience Reports 40:9.
Crossref
Crossref
Majid Mojarrad & Meysam Moghbeli. (2020) Genetic and molecular biology of bladder cancer among Iranian patients. Molecular Genetics & Genomic Medicine 8:6.
Crossref
Crossref
Mohammed Alsheikh, Mohammad Faruquz Zaman, Preethi Gopinath & Ahmed Qteishat. (2020) Bladder Stones Associated with an Aggressive Plasmacytoid Variant of Urothelial Cancer: A Rare Case and Literature Review. Current Urology 13:4, pages 217-223.
Crossref
Crossref
Liang Cheng, Antonio Lopez-Beltran, Gregory T. MacLennan, Rodolfo Montironi & David G. Bostwick. 2020. Urologic Surgical Pathology. Urologic Surgical Pathology
230
321.e19
.
Robert Lewis Maynard & Noel Downes. 2019. Anatomy and Histology of the Laboratory Rat in Toxicology and Biomedical Research. Anatomy and Histology of the Laboratory Rat in Toxicology and Biomedical Research
197
206
.
Xiangrui Yin, Wei Xiong, You Wang, Wei Tang, Wang Xi, Shengqiang Qian & Yu Guo. (2018) Association of CYP2E1 gene polymorphisms with bladder cancer risk. Medicine 97:39, pages e11910.
Crossref
Crossref
Samuel M. Cohen. (2018) Screening for human urinary bladder carcinogens: two-year bioassay is unnecessary. Toxicology Research 7:4, pages 565-575.
Crossref
Crossref
Min Soo Choo. 2018. Bladder Cancer. Bladder Cancer
45
55
.
S.M. Cohen. 2018. Comprehensive Toxicology. Comprehensive Toxicology
226
247
.
Morgan L. Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Maria Del Carmen Rodriguez Pena, Christopher J. VandenBussche, Mathew T. Olson, Isabela Cunha, Kazutoshi Fujita, Dilek Ertoy, Kenneth Kinzler, Trinity Bivalacqua, Nickolas Papadopoulos, Bert Vogelstein & George J. Netto. (2016) Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder. Human Pathology 53, pages 8-13.
Crossref
Crossref
Morgan Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Christopher J VandenBussche, Matthew T Olson, Isabela Cunha, Kazutoshi Fujita, Dilek Ertoy, Trinity J Bivalacqua, Kenneth Kinzler, Bert Vogelstein, George J Netto & Nickolas Papadopoulos. (2016) High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder. Modern Pathology 29:5, pages 511-515.
Crossref
Crossref
Semih Can Akincilar, Bilal Unal & Vinay Tergaonkar. (2016) Reactivation of telomerase in cancer. Cellular and Molecular Life Sciences 73:8, pages 1659-1670.
Crossref
Crossref
Samuel M. Cohen & Lora L. Arnold. (2016) Critical role of toxicologic pathology in a short-term screen for carcinogenicity. Journal of Toxicologic Pathology 29:4, pages 215-227.
Crossref
Crossref
Christian Bolenz & Thomas Martini. 2016. Die Urologie. Die Urologie
687
693
.
Shi Deng, Wei Wang, Xiang Li & Peng Zhang. (2015) Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer. World Journal of Surgical Oncology 13:1.
Crossref
Crossref
G. G. Ceylan, C. Ceylan, S. Taşdemir & A. Gözalan. (2014) The effect of Glutathione-S-transferases in the susceptibility to bladder cancer. Irish Journal of Medical Science (1971 -) 184:4, pages 851-854.
Crossref
Crossref
SUNG LYEA PARK, TAE-MIN CHO, SE YEON WON, JUN-HUI SONG, DAE-HWA NOH, WUN-JAE KIM & SUNG-KWON MOON. (2015) MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression. Oncology Reports 34:3, pages 1605-1612.
Crossref
Crossref
Fei Liu, Li-Mei Luo, Yong-Gang Wei, Bo Li, Wen-Tao Wang, Tian-Fu Wen, Jia-Yin Yang, Ming-Qing Xu & Lv-Nan Yan. (2015) Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population. Gene 564:1, pages 14-20.
Crossref
Crossref
Christopher S. Foster & George J. Netto. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
2322
2412
.
YINZHOU SHEN, XUELEI WANG, YONGCHAO JIN, JIASUN LU, GUANGMING QIU & XIAOFEI WEN. (2014) Differentially expressed genes and interacting pathways in bladder cancer revealed by bioinformatic analysis. Molecular Medicine Reports 10:4, pages 1746-1752.
Crossref
Crossref
Sergey L Yarosh, Elena V Kokhtenko, Mikhail I Churnosov, Alexander V Ataman, Maria A Solodilova & Alexey V Polonikov. (2014) Synergism between the N-acetyltransferase 2 gene and oxidant exposure increases the risk of idiopathic male infertility. Reproductive BioMedicine Online 29:3, pages 362-369.
Crossref
Crossref
YANFENG YANG, XUEPEI ZHANG, DONGKUI SONG & JINXING WEI. (2014) Association between vascular endothelial growth factor gene polymorphisms and bladder cancer risk. Molecular and Clinical Oncology 2:4, pages 501-505.
Crossref
Crossref
Raju K. Mandal, Sandhya Dubey, Aditya K. Panda & Rama D. Mittal. (2014) Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis. Tumor Biology 35:7, pages 6415-6423.
Crossref
Crossref
Jun Lin, Qiang Zhang, Yi Lu, Wenrui Xue, Yue Xu, Yichen Zhu & Xiaopeng Hu. (2014) Downregulation of HIPK2 Increases Resistance of Bladder Cancer Cell to Cisplatin by Regulating Wip1. PLoS ONE 9:5, pages e98418.
Crossref
Crossref
Jamie C. Messer, Shahrokh F. Shariat, Colin P. Dinney, Giacomo Novara, Yves Fradet, Wassim Kassouf, Pierre I. Karakiewicz, Hans-Martin Fritsche, Jonathan I. Izawa, Yair Lotan, Eila C. Skinner, Derya Tilki, Vincenzo Ficarra, Bjoern G. Volkmer, Hendrik Isbarn, Caimiao Wei, Seth P. Lerner, Tyler J. Curiel, Ashish M. Kamat & Robert S. Svatek. (2014) Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis. Urology 83:4, pages 863-868.
Crossref
Crossref
Julian Ollesch, Margot Heinze, H. Michael Heise, Thomas Behrens, Thomas Brüning & Klaus Gerwert. (2014) It's in your blood: spectral biomarker candidates for urinary bladder cancer from automated FTIR spectroscopy. Journal of Biophotonics 7:3-4, pages 210-221.
Crossref
Crossref
Qiliu Peng, Cuiju Mo, Weizhong Tang, Zhiping Chen, Ruolin Li, Limin Zhai, Shi Yang, Junrong Wu, Jingzhe Sui, Shan Li & Xue Qin. (2013) DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis. Tumor Biology 35:3, pages 1933-1944.
Crossref
Crossref
Qingtong Ma, Yumei Zhao, Shoufeng Wang, Xiaoyan Zhang, Jinling Zhang, Mei Du, Liang Li & Yun Zhang. (2013) Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies. Tumor Biology 35:2, pages 1473-1480.
Crossref
Crossref
Sabrieh AminiFardin FathiJafar MobalegiHeshmatollah SofimajidpourTayyeb Ghadimi. (2014) The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anatomy & Cell Biology 47:1, pages 1.
Crossref
Crossref
Marino E. Leon, Dahui Qin & Debra L. Zynger. 2014. Molecular Pathology and Diagnostics of Cancer. Molecular Pathology and Diagnostics of Cancer
329
340
.
Christian Bolenz & Thomas Martini. 2015. Die Urologie. Die Urologie
1
11
.
Szu-Han Chen, Wen-Jeng Wu, Hung-Pin Tu, Wei-Ming Li, Chun-Nung Huang, Ching-Chia Li, Hui-Hui Lin & Hung-Lung Ke. (2013) Glutathione S-Transferase Expression in Upper Urinary Tract Urothelial Carcinomas: a Taiwan Study. Asian Pacific Journal of Cancer Prevention 14:11, pages 6475-6479.
Crossref
Crossref
Bin Zhou, Peng Zhang, Yanyun Wang, Shaoqing Shi, Kui Zhang, Hong Liao & Lin Zhang. (2012) Interleukin‐17 gene polymorphisms are associated with bladder cancer in a chinese han population. Molecular Carcinogenesis 52:11, pages 871-878.
Crossref
Crossref
P. Sivaramakrishna RachakondaIsmail HosenPetra J. de VerdierMahdi FallahBarbara HeidenreichCharlotta RykN. Peter WiklundGunnar SteineckDirk Schadendorf, Kari Hemminki & Rajiv Kumar. (2013)
TERT
promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
. Proceedings of the National Academy of Sciences 110:43, pages 17426-17431.
Crossref
Crossref
Mohammad Reza Safarinejad, Saba Safarinejad, Nayyer Shafiei & Shiva Safarinejad. (2013) Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Urologic Oncology: Seminars and Original Investigations 31:7, pages 1193-1203.
Crossref
Crossref
Kai Li, Yong ping Hu, Zecheng Yang & Tongxin Sun. (2013) Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis. Tumor Biology 34:5, pages 2565-2572.
Crossref
Crossref
Wei Wang, Jia-Lin Li, Xiao-Feng He, An-Ping Li, Yong-Lin Cai, Na Xu, Shu-Mei Sun & Bing-Yi Wu. (2013) Association between the RAD51 135 G>C Polymorphism and Risk of Cancer: A Meta-Analysis of 19,068 Cases and 22,630 Controls. PLoS ONE 8:9, pages e75153.
Crossref
Crossref
Shan Li, Qiliu Peng, Yongbin Chen, Jianpeng You, Zhiping Chen, Yan Deng, Xianjun Lao, Huiling Wu, Xue Qin & Zhiyu Zeng. (2013) DNA Repair Gene XRCC1 Polymorphisms, Smoking, and Bladder Cancer Risk: A Meta-Analysis. PLoS ONE 8:9, pages e73448.
Crossref
Crossref
Natalia Gladkova, Elena Kiseleva, Olga Streltsova, Natalia Prodanets, Ludmila Snopova, Maria Karabut, Ekaterina Gubarkova & Elena Zagaynova. (2013) Combined use of fluorescence cystoscopy and cross‐polarization OCT for diagnosis of bladder cancer and correlation with immunohistochemical markers. Journal of Biophotonics 6:9, pages 687-698.
Crossref
Crossref
C.‐X. Yang, C.‐Y. Li & W. Feng. (2013) Toll‐like receptor 4 genetic variants and prognosis of breast cancer. Tissue Antigens 81:4, pages 221-226.
Crossref
Crossref
Yizhen Shen, Yi Liu, Shaoge Liu & Aimin Zhang. (2012) Toll-like Receptor 4 Gene Polymorphisms and Susceptibility to Bladder Cancer. Pathology & Oncology Research 19:2, pages 275-280.
Crossref
Crossref
Julian Ollesch, Steffen L. Drees, H. Michael Heise, Thomas Behrens, Thomas Brüning & Klaus Gerwert. (2013) FTIR spectroscopy of biofluids revisited: an automated approach to spectral biomarker identification. The Analyst 138:14, pages 4092.
Crossref
Crossref
Samuel M. Cohen. 2013. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
1775
1793
.
Yi Zheng, Shasha Tao, Fangru Lian, Binh T. Chau, Jie Chen, Guifan Sun, Deyu Fang, R. Clark Lantz & Donna D. Zhang. (2012) Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response. Toxicology and Applied Pharmacology 265:3, pages 292-299.
Crossref
Crossref
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
137
159
.
Yizhen ShenYi LiuShaoge LiuAimin Zhang. (2012) The Association Between -330T/G Polymorphism of Interleukin 2 Gene and Bladder Cancer. DNA and Cell Biology 31:6, pages 983-987.
Crossref
Crossref
Yun-Ling Zheng, Sania Amr, Doa'a A. Saleh, Chiranjeev Dash, Sameera Ezzat, Nabiel N. Mikhail, Iman Gouda, Iman Loay, Tamer Hifnawy, Mohamed Abdel-Hamid, Hussein Khaled, Beverly Wolpert, Mohamed A. Abdel-Aziz & Christopher A. Loffredo. (2012) Urinary Bladder Cancer Risk Factors in Egypt: A Multicenter Case–Control Study. Cancer Epidemiology, Biomarkers & Prevention 21:3, pages 537-546.
Crossref
Crossref
Qinbo Yuan, Meilin Wang, Miaomiao Wang, Zhengdong Zhang & Wei Zhang. (2011) Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case–control analysis. Molecular Biology Reports 39:3, pages 3109-3115.
Crossref
Crossref
Giovanni Brambilla, Francesca Mattioli, Luigi Robbiano & Antonietta Martelli. (2012) Update of carcinogenicity studies in animals and humans of 535 marketed pharmaceuticals. Mutation Research/Reviews in Mutation Research 750:1, pages 1-51.
Crossref
Crossref
Rong-Miao Zhou, Chao-Xu Niu, Na Wang, Zhi-Feng Chen, Shu-En Lei & Yan Li. (2012) ERCC1 Gene +262A/C Polymorphism Associated with Risk of Gastric Cardiac Adenocarcinoma in Nonsmokers. Archives of Medical Research 43:1, pages 67-74.
Crossref
Crossref
Peter Spieler & Matthias RösslePeter Spieler & Matthias Rössle. 2012. Nongynecologic Cytopathology. Nongynecologic Cytopathology
797
849
.
Mohammad Reza Safarinejad, Nayyer Shafiei & Shiva Safarinejad. (2010) Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. Medical Oncology 28:S1, pages 398-412.
Crossref
Crossref
Fei Liu, Bo Li, Yong-Gang Wei, Xi Chen, Yu Ma, Lv-Nan Yan, Tian-Fu Wen, Ming-Qing Xu, Wen-Tao Wang & Jia-Yin Yang. (2011) IFN-γ+874 A/T polymorphism and cancer risk: An updated analysis based on 32 case-control studies. Cytokine 56:2, pages 200-207.
Crossref
Crossref
Zheng Jiang, Chunxiang Li & Xishan Wang. (2011)
Glutathione
S
-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies
. Experimental Biology and Medicine 236:6, pages 723-728.
Crossref
Crossref
Meilin Wang, Haiyan Chu, Fu Yan, Chao Qin, Pu Li, Lin Yuan, Changjun Yin, Jianfeng Xu & Zhengdong Zhang. (2011) Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population. Carcinogenesis 32:6, pages 872-875.
Crossref
Crossref
Liang Cheng, Shaobo Zhang, Gregory T. MacLennan, Sean R. Williamson, Antonio Lopez-Beltran & Rodolfo Montironi. (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Human Pathology 42:4, pages 455-481.
Crossref
Crossref
Fuyuan Li, Chunxiang Li, Zheng Jiang, Ning Ma & Xu Gao. (2011) XRCC3 T241M Polymorphism and Bladder Cancer Risk: A Meta-analysis. Urology 77:2, pages 511.e1-511.e5.
Crossref
Crossref
RongGui ZhangGuangYong XuWenJun ChenWeiLi Zhang. (2011)
Genetic Polymorphisms of Glutathione
S
-Transferase P1 and Bladder Cancer Susceptibility in a Chinese Population
. Genetic Testing and Molecular Biomarkers 15:1-2, pages 85-88.
Crossref
Crossref
Johannes Falke & J. Alfred Witjes. (2011) Contemporary management of low-risk bladder cancer. Nature Reviews Urology 8:1, pages 42-49.
Crossref
Crossref
Hassan Abol-Enein, Bruce R. Kava & Adrienne J. K. Carmack. 2011. Bladder Tumors:. Bladder Tumors:
433
456
.
Da‐Tian Bau, Chao‐Hsiang Chang, Ming‐Hsui Tsai, Chang‐Fang Chiu, Yung‐An Tsou, Rou‐Fen Wang, Chia‐Wen Tsai & Ru‐Yin Tsai. (2010) Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility. The Laryngoscope 120:12, pages 2417-2422.
Crossref
Crossref
Seyyed Yousof Hosseini, Mohammad Reza Safarinejad, Erfan Amini & Hassan Hooshyar. (2010) Opium consumption and risk of bladder cancer: A case-control analysis. Urologic Oncology: Seminars and Original Investigations 28:6, pages 610-616.
Crossref
Crossref
Vincent E. Friedewald, Joel S. Bennett, J. Paul Christo, James L. Pool, James M. Scheiman, Lee S. Simon, Vibeke Strand, William B. White, Gary W. Williams & William C. Roberts. (2010) AJC Editor's Consensus: Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk. The American Journal of Cardiology 106:6, pages 873-884.
Crossref
Crossref
Y.-C. Su, J.-S. Lin, M.-T. Michael Lee, T.-C. Li & S.-M. Lee. (2010) Re: Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk. JNCI Journal of the National Cancer Institute 102:13, pages 988-988.
Crossref
Crossref
Samuel M. Cohen, Lora L. Arnold & Shugo Suzuki. 2010. Cancer Risk Assessment. Cancer Risk Assessment
501
514
.
Meilin WangChao QinJian ZhuLin YuanGuangbo FuZhengdong ZhangChangjun Yin. (2010)
Genetic Variants of
XRCC1
,
APE1
, and
ADPRT
Genes and Risk of Bladder Cancer
. DNA and Cell Biology 29:6, pages 303-311.
Crossref
Crossref
Ming Yin, Jingrong Yan, Sheng Wei & Qingyi Wei. (2010) CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis 31:5, pages 850-857.
Crossref
Crossref
Alexandre R. Zlotta, Samuel M. Cohen, Colin Dinney, Michael Droller, Theo H. van der Kwast, Bas W.G. van Rhijn, Bernard Bochner, Gilad Ameil & Michael A.S. Jewett. (2010) BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer. Urologic Oncology: Seminars and Original Investigations 28:3, pages 329-333.
Crossref
Crossref
M Wang, M Wang, L Yuan, D Wu, Z Zhang, C Yin, G Fu, Q Wei & Z Zhang. (2010) A novel XPF −357A>C polymorphism predicts risk and recurrence of bladder cancer. Oncogene 29:13, pages 1920-1928.
Crossref
Crossref
Tielong TangShu CuiXianzhong DengZhiyong GongGuo JiangPingxi WangBo LiaoZhonghai FeiShuyan XianDenang ZengJianyong Li. (2010)
Insertion/Deletion Polymorphism in the Promoter Region of
NFKB1
Gene Increases Susceptibility for Superficial Bladder Cancer in Chinese
. DNA and Cell Biology 29:1, pages 9-12.
Crossref
Crossref
S.M. Cohen. 2010. Comprehensive Toxicology. Comprehensive Toxicology
229
253
.
Chunxiang Li, Zheng Jiang & Xinghan Liu. (2009) XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis. Molecular Biology Reports 37:1, pages 301-309.
Crossref
Crossref
Frederike L. Büchner, H. Bas Bueno‐de‐Mesquita, Martine M. Ros, Ellen Kampman, Lars Egevad, Kim Overvad, Ole Raaschou‐Nielsen, Anne Tjønneland, Nina Roswall, Francoise Clavel‐Chapelon, Marie‐Christine Boutron‐Ruault, Marina Touillaud, Jenny Chang‐Claude, Rudolf Kaaks, Heiner Boeing, Steffen Weikert, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli, Sabina Sieri, Paolo Vineis, Rosario Tumino, Salvatore Panico, Alina Vrieling, Petra H.M. Peeters, Carla H. van Gils, Eiliv Lund, Inger T. Gram, Dagrun Engeset, Carmen Martinez, Carlos A. Gonzalez, Nerea Larrañaga, Eva Ardanaz, Carmen Navarro, Laudina Rodríguez, Jonas Manjer, Roy A. Ehrnström, Goran Hallmans, Borje Ljungberg, Naomi E. Allen, Andrew W. Roddam, Sheila Bingham, Kay‐Tee Khaw, Nadia Slimani, Paolo Boffetta, Mazda Jenab, Traci Mouw, Dominique S. Michaud, Lambertus A.L.M. Kiemeney & Elio Riboli. (2009) Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer 125:11, pages 2643-2651.
Crossref
Crossref
Zhizhong Zhang, Lixin Qiu, Meilin Wang, Na Tong, Jin Li & Zhengdong Zhang. (2009) The FAS ligand promoter polymorphism, rs763110 (−844C>T), contributes to cancer susceptibility: evidence from 19 case–control studies. European Journal of Human Genetics 17:10, pages 1294-1303.
Crossref
Crossref
Bo Chen, Shan Liu, Xue-Li Wang, Wei Xu, Yan Li, Wei-Hong Zhao & Jian-Qing Wu. (2009) TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis. European Journal of Cancer 45:14, pages 2598-2605.
Crossref
Crossref
J. M. Jonasson, R. Ljung, M. Talbäck, B. Haglund, S. Gudbjörnsdòttir & G. Steineck. (2009) Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden. Diabetologia 52:9, pages 1745-1754.
Crossref
Crossref
M. Nasterlack, P. Messerer, D. Pallapies, M. G. Ott & A. Zober. (2009) Cancer incidence in the wastewater treatment plant of a large chemical company. International Archives of Occupational and Environmental Health 82:7, pages 851-856.
Crossref
Crossref
Meilin Wang, Miaomiao Wang, Wei Zhang, Lin Yuan, Guangbo Fu, Qingyi Wei & Zhengdong Zhang. (2009) Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis 30:6, pages 991-996.
Crossref
Crossref
Meilin Wang, Zhizhong Zhang, Yuanyuan Tian, Jianfeng Shao & Zhengdong Zhang. (2009)
A Six-Nucleotide Insertion-Deletion Polymorphism in the
CASP8
Promoter Associated with Risk and Progression of Bladder Cancer
. Clinical Cancer Research 15:7, pages 2567-2572.
Crossref
Crossref
Zhizhong Zhang, Hengchuan Xue, Weida Gong, Meilin Wang, Lin Yuan, Suping Han & Zhengdong Zhang. (2009) FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case–control studies. Carcinogenesis 30:3, pages 487-493.
Crossref
Crossref
Meilin Wang, Haixia Zhu, Guangbo Fu, Miaomiao Wang, Zhizhong Zhang, Qiang Lu, Shizhi Wang & Zhengdong Zhang. (2008) Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case–control study with meta-analysis. Clinical and Experimental Medicine 9:1, pages 9-19.
Crossref
Crossref
Meilin Wang, Miaomiao Wang, Gong Cheng, Zhizhong Zhang, Guangbo Fu & Zhengdong Zhang. (2009) Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 661:1-2, pages 85-92.
Crossref
Crossref
Dong-Kui Song, Dong-Liang Xing, Li-Rong Zhang, Zhong-Xue Li, Jian Liu & Bao-Ping Qiao. (2009) Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detection and Prevention 32:5-6, pages 416-423.
Crossref
Crossref
Marcus Horstmann, Ralf Witthuhn, Markus Falk & Arnulf Stenzl. (2008) Gender-specific differences in bladder cancer: A retrospective analysis. Gender Medicine 5:4, pages 385-394.
Crossref
Crossref
David Schilling, Marcus Horstmann, Udo Nagele, Karl‐Dietrich Sievert & Arnulf Stenzl. (2008) Cystectomy in women. BJU International 102:9b, pages 1289-1295.
Crossref
Crossref
Zhizhong Zhang, Shizhi Wang, Meilin Wang, Na Tong, Guangbo Fu & Zhengdong Zhang. (2008) Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis. Carcinogenesis 29:10, pages 1973-1978.
Crossref
Crossref
Martina Hager, Gregor Mikuz, Heike Haufe, Christian Kolbitsch, Katharina B. Moser & Patrizia L. Moser. (2008) Association between atherosclerosis and urothelial tumors of the renal pelvis. World Journal of Urology 26:4, pages 375-379.
Crossref
Crossref
Guilherme Francisco, Paulo Rossi Menezes, Jose Eluf-Neto & Roger Chammas. (2008) XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. European Journal of Human Genetics 16:6, pages 724-734.
Crossref
Crossref
Benkang Shi, Keqin Zhang, Jing Zhang, Jun Chen, Nianzhao Zhang & Zhishun Xu. (2008) Relationship Between Patient Age and Superficial Transitional Cell Carcinoma Characteristics. Urology 71:6, pages 1186-1190.
Crossref
Crossref
Se-Jung Lee, Young-Hwa Cho, Keerang Park, Eun-Jung Kim, Kyung-Hwan Jung, Sung-Soo Park, Wun-Jae Kim & Sung-Kwon Moon. (2008) Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Biochemical Pharmacology 75:12, pages 2289-2300.
Crossref
Crossref
Jianfeng Shao, Min Gu, Zhendong Zhang, Zhuoqun Xu, Qiang Hu & Lixin Qian. (2008) Genetic variants of the cytochrome P450 and glutathione S‐transferase associated with risk of bladder cancer in a south‐eastern Chinese population. International Journal of Urology 15:3, pages 216-221.
Crossref
Crossref
Shouyu Wang, Meilin Wang, Shiwei Yin, Guangbo Fu, Chunping Li, Rui Chen, Aiping Li, Jianwei Zhou, Zhengdong Zhang & Qizhan Liu. (2008) A novel variable number of tandem repeats (VNTR) polymorphism containing Sp1 binding elements in the promoter of XRCC5 is a risk factor for human bladder cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 638:1-2, pages 26-36.
Crossref
Crossref
Samuel M. Cohen. (2008) Thresholds in Genotoxicity and Carcinogenicity: Urinary Bladder Carcinogenesis. Genes and Environment 30:4, pages 132-138.
Crossref
Crossref
Liang Cheng, Antonio Lopez-Beltran, Gregory T. MacLennan, Rodolfo Montironi & David G. Bostwick. 2008. Urologic Surgical Pathology. Urologic Surgical Pathology
258
351
.
Jianfeng Shao, Min Gu, Zhuoqun Xu, Qiang Hu & Lixin Qian. (2007) Polymorphisms of the DNA gene XPD and risk of bladder cancer in a Southeastern Chinese population. Cancer Genetics and Cytogenetics 177:1, pages 30-36.
Crossref
Crossref
Reina García-Closas, Montserrat García-Closas, Manolis Kogevinas, Núria Malats, Debra Silverman, Consol Serra, Adonina Tardón, Alfredo Carrato, Gemma Castaño-Vinyals, Mustafa Dosemeci, Lee Moore, Nathaniel Rothman & Rashmi Sinha. (2007) Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. European Journal of Cancer 43:11, pages 1731-1740.
Crossref
Crossref
Samuel M. Cohen, Takamasa Ohnishi, Nicole M. Clark, Jun He & Lora L. Arnold. (2016) Investigations of Rodent Urinary Bladder Carcinogens: Collection, Processing, and Evaluation of Urine and Bladders. Toxicologic Pathology 35:3, pages 337-347.
Crossref
Crossref
Edwin Hungerhuber, Herbert Stepp, Martin Kriegmair, Christian Stief, Alfons Hofstetter, Arndt Hartmann, Ruth Knuechel, Alexander Karl, Stefan Tritschler & Dirk Zaak. (2007) Seven Years’ Experience with 5-Aminolevulinic Acid in Detection of Transitional Cell Carcinoma of the Bladder. Urology 69:2, pages 260-264.
Crossref
Crossref
Hassan Abol-Enein, Bruce R. Kava & Adrienne J.K. Carmack. (2007) Nonurothelial Cancer of the Bladder. Urology 69:1, pages 93-104.
Crossref
Crossref
J.R. Meliker & J.O. Nriagu. 2007. Arsenic in Soil and Groundwater Environment - Biogeochemical Interactions, Health Effects and Remediation. Arsenic in Soil and Groundwater Environment - Biogeochemical Interactions, Health Effects and Remediation
551
584
.
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
SHIGERU SAKANO, RAJIV KUMAR, PER LARSSON, ERIK ONELÖV, JAN ADOLFSSON, GUNNAR STEINECK & KARI HEMMINKI. (2005)
A single‐nucleotide polymorphism in the
XPG
gene, and tumour stage, grade, and clinical course in patients with nonmuscle‐invasive neoplasms of the urinary bladder
. BJU International 97:4, pages 847-851.
Crossref
Crossref
Chunping Li, Wei Wu, Jia Liu, Lixin Qian, Aiping Li, Kehu Yang, Qingyi Wei, Jianwei Zhou & Zhengdong Zhang. (2006) Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case–control analysis. Pharmacogenetics and Genomics 16:4, pages 245-251.
Crossref
Crossref
Chunping Li, Jia Liu, Aiping Li, Lixin Qian, Xinru Wang, Qingyi Wei, Jianwei Zhou & Zhengdong Zhang. (2005) Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: A case–control analysis. Cancer Letters 227:1, pages 49-57.
Crossref
Crossref
Yasuhiro Komiya, Hiromasa Tsukino, Hiroyuki Nakao, Yoshiki Kuroda, Hirohisa Imai & Takahiko Katoh. (2005) Human glutathion S-transferase A1 polymorphism and susceptibility to urothelial cancer in the Japanese population. Cancer Letters 221:1, pages 55-59.
Crossref
Crossref
T. Vovk, M. Bogataj, R. Roškar, V. Kmetec & A. Mrhar. (2005) Determination of main low molecular weight antioxidants in urinary bladder wall using HPLC with electrochemical detector. International Journal of Pharmaceutics 291:1-2, pages 161-169.
Crossref
Crossref
Charlotta Ryk, Petra Berggren, Rajiv Kumar, Kari Hemminki, Per Larsson, Gunnar Steineck, Bo Lambert & Sai‐Mei Hou. (2004)
Influence of
GSTM1, GSTT1, GSTP1
and
NAT2
genotypes on the
p53
mutational spectrum in bladder tumours
. International Journal of Cancer 113:5, pages 761-768.
Crossref
Crossref
Germar‐Michael Pinggera, Philip Lirk, Florian Bodogri, Ralf Herwig, Gabriele Steckel‐Berger, Georg Bartsch & Josef Rieder. (2005) Urinary acetonitrile concentrations correlate with recent smoking behaviour. BJU International 95:3, pages 306-309.
Crossref
Crossref
Reimar R. W. Gaertner, Ljiljana Trpeski & Kenneth C. Johnson. (2004) A case?control study of occupational risk factors for bladder cancer in Canada. Cancer Causes and Control 15:10, pages 1007-1019.
Crossref
Crossref
Ralph Madeb & Edward M. Messing. (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urologic Oncology: Seminars and Original Investigations 22:2, pages 86-92.
Crossref
Crossref
Edward J Yun, Maxwell V Meng & Peter R Carroll. (2004) Evaluation of the patient with hematuria. Medical Clinics of North America 88:2, pages 329-343.
Crossref
Crossref
J.L. Landry, A. Gelet, R. Bouvier, J.M. Dubernard, X. Martin & M. Colombel. (2003) Detection of bladder dysplasia using 5‐aminolaevulinic acid‐induced porphyrin fluorescence. BJU International 91:7, pages 623-626.
Crossref
Crossref
Vladan Radosavljevic, Milena Ilic & Svetlana Jankovic. (2003) Epidemiologija I faktori rizika za nastanak raka mokracne besike. Vojnosanitetski pregled Military Medical and Pharmaceutical Journal of Serbia 60:2, pages 195-202.
Crossref
Crossref
Evan A. Ashkin & David K. Ornstein. 2003. Family Medicine. Family Medicine
852
858
.
Chris Leo Pashos, Marc F. Botteman, Benjamin Lewis Laskin & Alberto Redaelli. (2002) Bladder Cancer. Cancer Practice 10:6, pages 311-322.
Crossref
Crossref
N. V. Chandrasekharan, Hu Dai, K. Lamar Turepu Roos, Nathan K. Evanson, Joshua Tomsik, Terry S. Elton & Daniel L. Simmons. (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proceedings of the National Academy of Sciences 99:21, pages 13926-13931.
Crossref
Crossref
Dirk Zaak, Edwin Hungerhuber, Peter Schneede, Herbert Stepp, Dominic Frimberger, Stefan Corvin, Nikolaus Schmeller, Martin Kriegmair, Alfons Hofstetter & Ruth Knöchel. (2002) Role of 5‐aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 95:6, pages 1234-1238.
Crossref
Crossref
Adrian Simoes. 2002. Key Topics in General Surgery. Key Topics in General Surgery
70
72
.
S.M. Cohen, S.L. Johansson, L.L. Arnold & T.A. Lawson. (2002) Urinary tract calculi and thresholds in carcinogenesis. Food and Chemical Toxicology 40:6, pages 793-799.
Crossref
Crossref